From: www.ecancer.tv on Thu, Sep 02 2010 1:21 PM

Dr Bernardo Bonanni - European Institute of Oncology, Milan, Italy, speaking at the 12th Milan Breast Cancer Conference, June 2010. High risk clinic: follow-up of healthy individuals with genetic predisposition to breast cancer. Download the slides here.

From: www.ecancer.tv on Thu, Sep 02 2010 1:21 PM

Dr Andrea Decensi, Medical Oncology Unit, Galliera Hospital, Genoa, Italy, speaking at the 12th Milan Breast Cancer Conference, June 2010: Metabolic syndrome and breast cancer prevention. Download the slides here.

From: www.ecancer.tv on Thu, Sep 02 2010 10:32 AM

Prof Norbert Avril talking at the 12th Milan Breast Cancer Conference, June 2010 : PET scans in staging and treatment of breast cancer.

From: www.ecancer.tv on Tue, Aug 17 2010 1:04 PM

Prof Caldas discusses his research which has revealed that women who had a bad prognosis at time of breast cancer diagnosis but have survived for five years have a much better chance of survival thereafter than women who had a good prognosis at time of diagnosis. Prof Caldas then speaks about the...

From: www.ecancer.tv on Tue, Aug 17 2010 11:55 AM

Dr Balmain speaks to ecancer.tv about his work identifying individuals who are highly susceptible to cancer. Dr Balmain discusses what information is used to determine cancer susceptibility in mice and suggests how he believes this research will be put to use.

From: www.ecancer.tv on Tue, Aug 17 2010 11:55 AM

Dr Jones speaks to ecancer.tv about the way epigenetics can be used to treat cancer, the progress that has been made in this field and the potential to use this technology to treat solid tumours. Dr Jones explains how this can be achieved by the reactivation of tumour suppressor genes.

From: www.ecancer.tv on Tue, Aug 17 2010 9:24 AM

Prof Esteller explains how epigenetics can be used to treat cancer. Prof Esteller’s lab has been working to find new genes that undergo epigenetic inactivation in cancer cells, carry out preclinical tests on epigenetic drugs and developing epigenetic biomarkers to predict response to chemotherapy.

From: www.ecancer.tv on Tue, Aug 17 2010 9:24 AM

Prof Helleday speaks about his work on the PARP inhibitors, how these can selectively kill recombination defective tumour cells and discusses the significance of homologous recombination in the development of cancer, in cancer therapies and in the resistance of cancer to treatment.

From: www.ecancer.tv on Tue, Aug 17 2010 9:24 AM

Prof van de Vijver discusses his work identifying genes that can be used to predict response to breast cancer treatment. Gene expression profiles of tumour samples are used to identify which genes are associated with response or no response to therapy. Prof van de Vijver explains how genetic prof...

From: www.ecancer.tv on Tue, Aug 17 2010 9:24 AM

Prof Helin speaks about his work using epigenetics to identify specific new targets for cancer therapy. Although the drugs Prof Helin is working on have not yet entered clinical trials, the research has shown promising results suggesting they will eventually be effective against a number of diff...

From: www.ecancer.tv on Tue, Aug 17 2010 9:24 AM

Prof Marais speaks about his research into the genetic influence of the B-RAF mutation in melanoma. Using mice as models for the disease, Prof Marais' team have been working to identify the mechanism of action of different melanoma therapies and to test the specificity of different drugs. T...

From: www.ecancer.tv on Tue, Aug 17 2010 9:24 AM

Prof Celis talks about the need for all stakeholders to work together to direct European cancer policy. To this end, ECCO have set up the European Academy of Cancer Sciences, a group of representatives from all cancer disciplines who can offer evidenced based advice to science policy makers. In ...

From: www.ecancer.tv on Tue, Aug 17 2010 9:24 AM

Prof Arnold Levine speaks about his work investigating the p53 gene and p53 protein. Cancer is often caused by mutation of a number of genes. Prof Levine explains how inactivation of these mutated genes can stop the cancer and describes how the p53 gene contributes to cancer prevention by maintai...

From: www.ecancer.tv on Sun, Aug 15 2010 4:54 AM

Dr Bertolini speaks to ecancer.tv about his research into anti-angiogenic therapy as treatment for breast cancer. Anti-angiogenic therapy has been successful increasing progression free survival, but has not yet achieved an increase in overall survival. Dr Bertolini’s team is now looking to see ...

From: www.ecancer.tv on Sun, Aug 15 2010 4:54 AM

Prof Rath speaks about the challenges faced trying to reduce the number of preventable cancer cases in India. The majority of these, 45% of the three million cancer cases being treated at any one time, are tobacco related. A major obstacle for Indian oncologists is that 80% of cancer cases are p...

From: www.ecancer.tv on Sun, Aug 15 2010 4:54 AM

Dr Sahni talks to ecancer.tv about the increased incidence of breast cancer in India. Although India does not have a national screening programme, there are programmes teaching women the importance of self examination. Dr Sahni suggests that the reluctance of Indian women to get screened is due ...

From: www.ecancer.tv on Thu, Aug 05 2010 6:15 AM

Prof Goldman discusses the recent developments in the treatment of chronic myeloid leukaemia, specifically the results of using 2nd generation tyrosine kinase inhibitors for treatment of chronic phase CML.

From: www.ecancer.tv on Thu, Aug 05 2010 6:15 AM

Dr Bullinger discusses the use of genomics technologies in acute myeloid leukaemia, in particular, the use of DNA microarrays. Microarrays are used as diagnostic tools to identify different leukaemia subtypes and identify molecular aberrations.

From: www.ecancer.tv on Thu, Aug 05 2010 6:15 AM

Dr Fielding discusses data from UKALL 12, a trial for adults with acute lymphoblastic leukaemia. Part of the trial evaluated the addition of the tyrosine kinase inhibitor, imatinib, to standard therapy.

From: www.ecancer.tv on Tue, Aug 03 2010 2:09 PM

Dr Cornes talks about how Cochrane groups benefit clinicians and discusses the alarming rise in endometrial cancer rates in the last decade. The increase has been attributed to our aging population, lifestyle issues such as obesity and the rise in diabetes/the metabolic syndrome. Dr Cornes talks...